Literature DB >> 30199303

Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging.

Danielle Mandikian1, Hanine Rafidi1, Pragya Adhikari2, Priya Venkatraman1, Lidia Nazarova1, Gabriel Fung1, Isabel Figueroa1, Gregory Z Ferl1, Sheila Ulufatu3, Jason Ho3, Cynthia McCaughey3, Jeffrey Lau4, Shang-Fan Yu4, Saileta Prabhu1, Jack Sadowsky2, C Andrew Boswell1.   

Abstract

Antibody pretargeting is a promising strategy for improving molecular imaging, wherein the separation in time of antibody targeting and radiolabeling can lead to rapid attainment of high contrast, potentially increased sensitivity, and reduced patient radiation exposure. The inverse electron demand Diels-Alder 'click' reaction between trans-cyclooctene (TCO) conjugated antibodies and radiolabeled tetrazines presents an ideal platform for pretargeted imaging due to rapid reaction kinetics, bioorthogonality, and potential for optimization of both slow and fast clearing components. Herein, we evaluated a series of anti-human epidermal growth factor receptor 2 (HER2) pretargeting antibodies containing distinct molar ratios of site-specifically incorporated TCO. The effect of stoichiometry on tissue distribution was assessed for pretargeting TCO-modified antibodies (monitored by 125I) and subsequent accumulation of an 111In-labeled tetrazine in a therapeutically relevant HER2+tumor-bearing mouse model. Single photon emission computed tomography (SPECT) imaging was also employed to assess tumor imaging at various TCO-to-monoclonal antibody (mAb) ratios. Increasing TCO-to-mAb molar ratios correlated with increased in vivo click reaction efficiency evident by increased tumor distribution and systemic exposure of 111In-labeled tetrazines. The pharmacokinetics of TCO-modified antibodies did not vary with stoichiometry. Pretargeted SPECT imaging of HER2-expressing tumors using 111In-labeled tetrazine demonstrated robust click reaction with circulating antibody at ~2 hours and good tumor delineation for both the 2 and 6 TCO-to-mAb ratio variants at 24 hours, consistent with a limited cell-surface pool of pretargeted antibody and benefit from further distribution and internalization. To our knowledge, this represents the first reported systematic analysis of how pretargeted imaging is affected solely by variation in click reaction stoichiometry through site-specific conjugation chemistry.

Entities:  

Keywords:  SPECT; biorthogonal click chemistry; iEDDA reaction; pretargeted imaging; site-specific bioconjugation; tetrazine

Mesh:

Substances:

Year:  2018        PMID: 30199303      PMCID: PMC6284555          DOI: 10.1080/19420862.2018.1521132

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  57 in total

1.  In vivo chemistry for pretargeted tumor imaging in live mice.

Authors:  Raffaella Rossin; Pascal Renart Verkerk; Sandra M van den Bosch; Roland C M Vulders; Iris Verel; Johan Lub; Marc S Robillard
Journal:  Angew Chem Int Ed Engl       Date:  2010-04-26       Impact factor: 15.336

2.  Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies.

Authors:  J Schuhmacher; S Kaul; G Klivényi; H Junkermann; A Magener; M Henze; J Doll; U Haberkorn; F Amelung; G Bastert
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

Review 3.  Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.

Authors:  C Andrew Boswell; Martin W Brechbiel
Journal:  Nucl Med Biol       Date:  2007-06-08       Impact factor: 2.408

4.  Pretargeted Immuno-PET Based on Bioorthogonal Chemistry for Imaging EGFR Positive Colorectal Cancer.

Authors:  Xudong Shi; Kai Gao; Hao Huang; Ran Gao
Journal:  Bioconjug Chem       Date:  2018-01-18       Impact factor: 4.774

5.  Effects of anti-VEGF on pharmacokinetics, biodistribution, and tumor penetration of trastuzumab in a preclinical breast cancer model.

Authors:  Cinthia V Pastuskovas; Eduardo E Mundo; Simon P Williams; Tapan K Nayak; Jason Ho; Sheila Ulufatu; Suzanna Clark; Sarajane Ross; Eric Cheng; Kathryn Parsons-Reponte; Gary Cain; Marjie Van Hoy; Nicholas Majidy; Sheila Bheddah; Josefa dela Cruz Chuh; Katherine R Kozak; Nicholas Lewin-Koh; Peter Nauka; Daniela Bumbaca; Mark Sliwkowski; Jay Tibbitts; Frank-Peter Theil; Paul J Fielder; Leslie A Khawli; C Andrew Boswell
Journal:  Mol Cancer Ther       Date:  2012-01-05       Impact factor: 6.261

6.  Preparation of tetrazine-containing [2 + 1] complexes of 99mTc and in vivo targeting using bioorthogonal inverse electron demand Diels-Alder chemistry.

Authors:  Abdolreza Yazdani; Nancy Janzen; Shannon Czorny; Robert G Ungard; Tanya Miladinovic; Gurmit Singh; John F Valliant
Journal:  Dalton Trans       Date:  2017-10-31       Impact factor: 4.390

Review 7.  Inverse Electron-Demand Diels-Alder Bioorthogonal Reactions.

Authors:  Haoxing Wu; Neal K Devaraj
Journal:  Top Curr Chem (Cham)       Date:  2015-12-22

8.  Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.

Authors:  Brian M Zeglis; Christian Brand; Dalya Abdel-Atti; Kathryn E Carnazza; Brendon E Cook; Sean Carlin; Thomas Reiner; Jason S Lewis
Journal:  Mol Pharm       Date:  2015-08-31       Impact factor: 4.939

Review 9.  Imaging of human epidermal growth factor receptors for patient selection and response monitoring - From PET imaging and beyond.

Authors:  Patricia M R Pereira; Lolkje Abma; Kelly E Henry; Jason S Lewis
Journal:  Cancer Lett       Date:  2018-04-10       Impact factor: 8.679

Review 10.  Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 1: Cysteine Residues and Glycans.

Authors:  Pierre Adumeau; Sai Kiran Sharma; Colleen Brent; Brian M Zeglis
Journal:  Mol Imaging Biol       Date:  2016-02       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.